Granulocyte colony-stimulating factor but not peritoneal lavage increases survival rate after experimental abdominal contamination and infection (Q44187070)

From Wikidata

Jump to navigation Jump to search

scientific article published in November 2002

Language	Label	Description	Also known as
English	Granulocyte colony-stimulating factor but not peritoneal lavage increases survival rate after experimental abdominal contamination and infection	scientific article published in November 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Granulocyte colony-stimulating factor but not peritoneal lavage increases survival rate after experimental abdominal contamination and infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

author name string

Bauhofer A

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Stinner B

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Kohlert F

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Reckzeh B

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Lorenz W

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Celik I

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

language of work or name

0 references

publication date

1 November 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

British Journal of Surgery

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

89

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1457-1464

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4). Protocol of a controlled [...]

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

Efficacy of metronidazole lavage in treatment of intraperitoneal sepsis. A prospective study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

The influence of lavage on peritonitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

Role of granulocyte colony-stimulating factor in the immune response to acute bacterial infection in the nonneutropenic host: an overview

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

Enhancement of neutrophil function by in vivo filgrastim treatment for prophylaxis of sepsis in surgical intensive care patients.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4). Protocol for a [...]

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : IV. THE MECHANISM OF PHAGOCYTOSIS IN THE ABSENCE OF ANTIBODY.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

Fecal peritonitis: microbial adherence to serosal mesothelium and resistance to peritoneal lavage.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

Hypothesis: compartmentalization of cytokines in intraabdominal infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

Peritoneal defences and peritoneum-associated lymphoid tissue

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

Peritoneal lavage in abdominal sepsis. A controlled clinical study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

Peritoneal lavage in appendicular peritonitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

Surgical therapy of diffuse peritonitis: debridement and intraoperative extensive lavage

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

Granulocyte colony-stimulating factor improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, and endothelin-1 in fulminant intra-abdominal sepsis in rats

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

Biases in reporting of trials

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

The adjuvant effect of peritoneal fluid in experimental peritonitis. Mechanism and clinical implications

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

Various intraperitoneal irrigation solutions in treating experimental fecal peritonitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

Intraperitoneal antiseptics in experimental bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

Effect of intraperitoneal antimicrobials on the concentration of bacteria, endotoxin, and tumor necrosis factor in abdominal fluid and plasma in rats

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

Perioperative lavage promotes intraperitoneal adhesion in the rat

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

Management of abdominal sepsis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

Host defense mechanisms of surgical patients. Friend or foe?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

Enhancement of peritoneal leukocyte function by granulocyte colony-stimulating factor in rats with abdominal sepsis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

Activation of neutrophil function by recombinant human granulocyte colony-stimulating factor improves the survival of rats with peritonitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02227.X

21 January 2018

Identifiers

10.1046/J.1365-2168.2002.02227.X

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44187070&oldid=2108349710"